-
Cellectis was
founded by André
Choulika in 1999. It
built up a
successful business based on the use of
Meganuclease in
genome engineering.
Cellectis became...
- 2016-02-19. "
Cellectis announces the
issuance by the
USPTO of a
patent covering a
seminal nuclease-based "gene editing"
method |
cellectis". www.
cellectis.com...
- Forum.
Retrieved 2019-02-13. "Our
Story |
Cellectis". www.
cellectis.com.
Retrieved 2019-02-13. "
Cellectis - gene
edited T-Cells".
Retrieved December...
-
Bantam Pharmaceutical Bioreclamation BioSpecifics Caladrius Biosciences Cellectis Certerra Chembio Diagnostic Systems Clinilabs Clinuvel Pharmaceuticals...
- (CH, 2014) In Oncology: CTI
BIOPHARMA (USA, 2014),
NOVARTIS (CH, 2014),
CELLECTIS (FR, 2014),
NERVIANO (IT, 2013), EOS (IT) /
CLOVIS (USA, 2012), BIOINVENT...
-
Editas Medicine,
Intellia Therapeutics,
CRISPR Therapeutics, Casebia,
Cellectis,
Precision Biosciences,
bluebird bio,
Excision BioTherapeutics, and Sangamo...
-
derived Cardiomyocytes are
available commercially from GE Healthcare,
Cellectis,
Reprocell and others.
iCell Cardiomyocytes have been
found to display...
- 2021. "CAR-T
Pioneer Dr.
Stephan A.
Grupp to Join
Cellectis Clinical Advisory Board".
cellectis.com.
September 19, 2018.
Retrieved February 14, 2021...
-
expert witness in a
biotechnology patent lawsuit between French firm
Cellectis and
Precision BioSciences, a
smaller American firm. Both
firms had developed...
- ISSN 1699-4019. PMID 31942876. McKee,
Selina (2017-09-05). "FDA
holds trials of
Cellectis' cell
therapy after patient death". www.pharmatimes.com.
Retrieved 2017-10-08...
